Assertio Targets Febrile Neutropenia Drug In Spectrum Buyout Deal

 
• By Alaric DeArment
  
Assertio said it would acquire Spectrum Pharmaceuticals for $248m • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business